Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Read more
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 Read more
Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study Read more
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients Read more
CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients Read more